Members
Members
Join FHI
Support services
Member overview
Vacancies
Join
Advocacy
Industries
Industries
Industrial Electronics
Industrial automation
Building Automation
Laboratory Technology
Knowledge hub
Knowledge hub
FHI News
Networks
Themes
Activities
About FHI
About FHI
About FHI
Join FHI
Management
Employers
Working at FHI
Contact
Search for:
Login
Sign up
Search for:
Menu
Home
Knowledge hub
Back
Knowledge hub
Clusters
Member overview
Industries
Back
Industries
Industrial automation
Laboratory Technology
Building Automation
Industrial Electronics
Activities
Back
Activities
World of Technology & Science
About FHI
Back
About FHI
Join
Contact
Management
Employers
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
QIAGEN Benelux
– December 2, 2021
Related articles
view profile
QIAGEN continues to update its range of automation solutions with the launch of high-sensitive capillary electrophoresis instrument QIAxcel Connect
QIAGEN Benelux
May 4, 2022
QIAGEN launches QIAwave portfolio of environmentally friendly products
QIAGEN Benelux
January 18, 2022
QIAGEN strengthens growing portfolio of applications for its digital PCR platform QIAcuity with new collaborations
QIAGEN Benelux
January 7, 2022
FHI, federatie van technologiebranches
Nederlands
Nederlands
_60572-300x100.jpg)
Nederlands